Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in the reduction of posttraumatic stress symptoms, depression, and anxiety, while improving the quality of life in individuals who have experienced traffic accidents. Using a randomized control design, participants aged 18-45 will be assessed at three-time points: pre-treatment, post-treatment, and one-month follow-up. The study employs the DASS-21, UIES-R, and WHOQOL-BREF as evaluation measures. Findings aim to expand evidence on trauma-focused interventions and explore their applicability in culturally diverse, resource-constrained settings.
Aged between 18 and 45 years.
Experienced a traffic accident 3 months to 10 years prior
Willing to participate and able to understand the intervention components.
Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study.
History of severe head injuries resulting in neurological or cognitive deficits.
Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized
Parallel
Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress
Other interventionEMDR-IGTP-OTS is a group intervention based on EMDR 8-phased protocols with the integration of the Butterfly hug technique.
The Urdu Impact of Event Scale-Revised
It will measure trauma-specific symptoms such as intrusion, avoidance, and hyperarousal. This 22-item scale uses a 5-point Likert scale ranging from 0 (not at all) to 4 (extreme), comprehensively evaluating the psychological impact of traumatic incidents. Higher the scores, Higher will be severity of post traumatic symptoms.
Click on the lead sponsor to view all of their trials.
